Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Maricel Apuli, officer

Transaction date: May 2, 2025

Reporting date: May 6, 2025

Average share price: 38.5079

Sold 1026.0 shares for 39509.11